Thought Leadership

Latest Report

Thumbnail

Vantage 2020 Preview

The Vantage 2020 Preview predicts a rocky year ahead, with areas of significant growth contrasting with investor uncertainty. The industry closed 2019 with a flourish, and areas like cancer, vaccines and diabetes are poised to continue this with strong sales in 2020. However, the wider sector will need to deliver on its innovation promises next…

Report library

Thumbnail

EvaluatePharma Orphan Drug Report 2019

$242bn forecasted orphan drug sales by 2024, one-fifth of the total worldwide pharmaceutical market The EvaluatePharma Orphan Drug Report 2019 arrives at the start of a…

Thumbnail

Vantage 2019 Preview

2019 expected to be volatile year for pharma and biotech industries The Vantage 2019 Preview looks at the risks and opportunities for the year ahead. Report…